Mylan Inc. (MYL)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 516.15m
  • Volume: 0
  • RiskGrade: 173

Latest ShareCast News

Mylan's Q2 revenues top expectations

By Iain Gilbert

Date: Monday 29 Jul 2019

(Sharecast News) - Generic pharmaceuticals maker Mylan shares shot up at the bell after posting a second-quarter revenue beat and agreeing to merge with Pfizer's off-patent unit.

Mylan ups revenue guidance after first-quarter miss

By Iain Gilbert

Date: Wednesday 09 May 2018

(Sharecast News) - American speciality pharmaceuticals company Mylan reported a fall in revenue for first-quarter on Wednesday but upped its full year guidance.

Mylan surges in pre-market trading after MS drug gets FDA approval

By Iain Gilbert

Date: Wednesday 04 Oct 2017

(ShareCast News) - US-based generic and speciality pharmaceuticals company Mylan announced on Tuesday that the US Food and Drug Administration (FDA) had approved two doses of its generic equivalent to Teva's drug Copaxone, which generated $1.02bn worth of sales in the second quarter of 2017, used to treat relapsing forms of multiple sclerosis.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Mylan Inc. Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 516.15m
RiskGrade 173

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page